ID

41233

Descripción

Safety and Efficacy Study of a Dual PI3K Delta/Gamma Inhibitor in Hematological Malignancies; ODM derived from: https://clinicaltrials.gov/show/NCT02017613

Link

https://clinicaltrials.gov/show/NCT02017613

Palabras clave

Versiones (1)
  1. 21/7/20 21/7/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

21 de julio de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Lymphoma, B-Cell NCT02017613

Inglés

Eligibility Lymphoma, B-Cell NCT02017613

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
refractory to or relapsed after at least 1 prior treatment line.
Descripción

Unresponsive to Treatment | Recurrent disease | Status post Therapeutic procedure Quantity

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0205269
UMLS CUI [2]
C0277556
UMLS CUI [3,1]
C0231290
UMLS CUI [3,2]
C0087111
UMLS CUI [3,3]
C1265611
ecog performance status ≤2
Descripción

ECOG performance status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
patients must be ≥18 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
able to give a written informed consent.
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any cancer therapy in the last 4 weeks or limited palliative radiation <2 weeks
Descripción

Cancer treatment | Palliative course of radiotherapy Limited

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0920425
UMLS CUI [2,1]
C0475092
UMLS CUI [2,2]
C0439801
patients with hbv, hcv or hiv infection
Descripción

Hepatitis B | Hepatitis C | HIV Infection

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019163
UMLS CUI [2]
C0019196
UMLS CUI [3]
C0019693
autologous hematologic stem cell transplant within 3 months of study entry. allogeneic hematologic stem cell transplant within 12 months.
Descripción

Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2193200
UMLS CUI [2]
C4255274
previous therapy with gs-1101 (cal-101, idelalisib), ipi-145, tgr-1202 or any drug that specifically inhibits pi3k/ mtor (including temsirolimus, everolimus), akt or btk inhibitor (including ibrutinib).
Descripción

GS-1101 | CAL 101 | idelalisib | IPI-145 | TGR-1202 | Phosphatidylinositide 3-Kinase Inhibitor | mTOR Inhibitor | temsirolimus | everolimus | AKT Inhibitor | BTK Inhibitor | ibrutinib

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3529624
UMLS CUI [2]
C2703131
UMLS CUI [3]
C2698692
UMLS CUI [4]
C3274621
UMLS CUI [5]
C3641791
UMLS CUI [6]
C1519050
UMLS CUI [7]
C2746052
UMLS CUI [8]
C1707080
UMLS CUI [9]
C0541315
UMLS CUI [10]
C4744361
UMLS CUI [11]
C4086017
UMLS CUI [12]
C3501358
patients on immunosuppressive therapy including systemic corticosteroids.
Descripción

Therapeutic immunosuppression | CORTICOSTEROIDS FOR SYSTEMIC USE

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021079
UMLS CUI [2]
C3653708
patients who are receiving chronic systemic anticoagulation therapy (warfarin sodium or heparin, etc.).
Descripción

Anticoagulation Therapy Systemic chronic | warfarin | sodium | heparin

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0003281
UMLS CUI [1,2]
C0205373
UMLS CUI [1,3]
C0205191
UMLS CUI [2]
C0043031
UMLS CUI [3]
C0037473
UMLS CUI [4]
C0019134
patients with known history of liver disorders.
Descripción

Liver disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023895
patients with uncontrolled diabetes type i or type ii
Descripción

Type 1 diabetes mellitus uncontrolled | Type II diabetes mellitus uncontrolled

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2732402
UMLS CUI [2]
C2733146
any severe and/or uncontrolled medical conditions or other conditions that could affect their participation in the study.
Descripción

Other medical condition Severe Affecting Study Subject Participation Status | Other medical condition Uncontrolled Affecting Study Subject Participation Status | Condition Affecting Study Subject Participation Status

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3843040
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C2348568
UMLS CUI [2,1]
C3843040
UMLS CUI [2,2]
C0205318
UMLS CUI [2,3]
C0392760
UMLS CUI [2,4]
C2348568
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0392760
UMLS CUI [3,3]
C2348568
women who are pregnant or lactating.
Descripción

Pregnancy | Breast Feeding

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Volver a la parte superior de la página

Similar models

Eligibility Lymphoma, B-Cell NCT02017613

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Unresponsive to Treatment | Recurrent disease | Status post Therapeutic procedure Quantity
Item
refractory to or relapsed after at least 1 prior treatment line.
boolean
C0205269 (UMLS CUI [1])
C0277556 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C1265611 (UMLS CUI [3,3])
ECOG performance status
Item
ecog performance status ≤2
boolean
C1520224 (UMLS CUI [1])
Age
Item
patients must be ≥18 years of age
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
able to give a written informed consent.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cancer treatment | Palliative course of radiotherapy Limited
Item
any cancer therapy in the last 4 weeks or limited palliative radiation <2 weeks
boolean
C0920425 (UMLS CUI [1])
C0475092 (UMLS CUI [2,1])
C0439801 (UMLS CUI [2,2])
Hepatitis B | Hepatitis C | HIV Infection
Item
patients with hbv, hcv or hiv infection
boolean
C0019163 (UMLS CUI [1])
C0019196 (UMLS CUI [2])
C0019693 (UMLS CUI [3])
Autologous hematopoietic stem cell transplant | Allogeneic hematopoietic stem cell transplant
Item
autologous hematologic stem cell transplant within 3 months of study entry. allogeneic hematologic stem cell transplant within 12 months.
boolean
C2193200 (UMLS CUI [1])
C4255274 (UMLS CUI [2])
GS-1101 | CAL 101 | idelalisib | IPI-145 | TGR-1202 | Phosphatidylinositide 3-Kinase Inhibitor | mTOR Inhibitor | temsirolimus | everolimus | AKT Inhibitor | BTK Inhibitor | ibrutinib
Item
previous therapy with gs-1101 (cal-101, idelalisib), ipi-145, tgr-1202 or any drug that specifically inhibits pi3k/ mtor (including temsirolimus, everolimus), akt or btk inhibitor (including ibrutinib).
boolean
C3529624 (UMLS CUI [1])
C2703131 (UMLS CUI [2])
C2698692 (UMLS CUI [3])
C3274621 (UMLS CUI [4])
C3641791 (UMLS CUI [5])
C1519050 (UMLS CUI [6])
C2746052 (UMLS CUI [7])
C1707080 (UMLS CUI [8])
C0541315 (UMLS CUI [9])
C4744361 (UMLS CUI [10])
C4086017 (UMLS CUI [11])
C3501358 (UMLS CUI [12])
Therapeutic immunosuppression | CORTICOSTEROIDS FOR SYSTEMIC USE
Item
patients on immunosuppressive therapy including systemic corticosteroids.
boolean
C0021079 (UMLS CUI [1])
C3653708 (UMLS CUI [2])
Anticoagulation Therapy Systemic chronic | warfarin | sodium | heparin
Item
patients who are receiving chronic systemic anticoagulation therapy (warfarin sodium or heparin, etc.).
boolean
C0003281 (UMLS CUI [1,1])
C0205373 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0043031 (UMLS CUI [2])
C0037473 (UMLS CUI [3])
C0019134 (UMLS CUI [4])
Liver disease
Item
patients with known history of liver disorders.
boolean
C0023895 (UMLS CUI [1])
Type 1 diabetes mellitus uncontrolled | Type II diabetes mellitus uncontrolled
Item
patients with uncontrolled diabetes type i or type ii
boolean
C2732402 (UMLS CUI [1])
C2733146 (UMLS CUI [2])
Other medical condition Severe Affecting Study Subject Participation Status | Other medical condition Uncontrolled Affecting Study Subject Participation Status | Condition Affecting Study Subject Participation Status
Item
any severe and/or uncontrolled medical conditions or other conditions that could affect their participation in the study.
boolean
C3843040 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C2348568 (UMLS CUI [1,4])
C3843040 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
C0392760 (UMLS CUI [2,3])
C2348568 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C0392760 (UMLS CUI [3,2])
C2348568 (UMLS CUI [3,3])
Pregnancy | Breast Feeding
Item
women who are pregnant or lactating.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial